-+ 0.00%
-+ 0.00%
-+ 0.00%

*AIM ImmunoTech: Assuming All Units Are Subscribed for, Company Expects Net Proceeds of About $10.65M, After Deducting Expenses

Dow Jones·01/23/2026 18:13:00

Please log in to view news